Maria Grazia Daidone

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Neoplasms 50%
3. Estrogen Receptors 32%
4. Telomerase 29%
5. Circulating Neoplastic Cells 21%
6. Thymidine 19%
7. Biomarkers 19%
8. Recurrence 17%
9. Telomere Homeostasis 17%
10. Cell Line 16%
11. Telomere 16%
12. Apoptosis 15%
13. Ovarian Neoplasms 14%
14. Melanoma 14%
15. Kinetics 14%
16. Neoplasm Metastasis 13%
17. human TERT protein 13%
18. Survivin 13%
19. Cell Proliferation 12%
20. Therapeutics 12%
21. Survival 11%
22. MicroRNAs 11%
23. Genes 11%
24. Neoadjuvant Therapy 11%
25. Neoplastic Stem Cells 10%
26. Cisplatin 10%
27. Hormones 10%
28. Ploidies 10%
29. In Vitro Techniques 10%
30. Catalytic RNA 10%
31. Butyric Acid 9%
32. Transcriptome 9%
33. Triple Negative Breast Neoplasms 9%
34. Tumor Biomarkers 9%
35. Growth 8%
36. Steroid Receptors 8%
37. Prostatic Neoplasms 8%
38. Tamoxifen 8%
39. Gene Expression 8%
40. Drug Therapy 8%
41. Pharmaceutical Preparations 8%
42. Breast 8%
43. Platinum 7%
44. Liposarcoma 7%
45. Adjuvant Chemotherapy 7%
46. Progesterone Receptors 7%
47. Paraffin 6%
48. Doxorubicin 6%
49. telomerase RNA 6%
50. Proteins 6%